The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

FDA uses a range of biocompatibility test data to evaluate medical devices before clearing or approving them for marketing. The growing use of FDA-recognized consensus standards facilitates this ...

BOENNIGHEIM, Germany and LIGONIER, Ind., Nov. 4, 2025 /PRNewswire/ -- Hohenstein Medical – a division of Hohenstein Laboratories and a leading provider of testing, research and certification services ...

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...

The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.

STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...

As medical device toxicology requirements continue to evolve, MCRA hires board certified toxicologist Sharlee More, PhD, DABT. Dr. More expands MCRA's biocompatibility services to include ...

Researchers have developed a surface treatment that could improve the body’s acceptance of medical devices such as joint replacements and stents, according to a Chemistry World report. The method ...

Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, ON, April 29, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology ...